Cargando…
Therapeutic effect of prostaglandin E1 in monocrotaline-induced pulmonary arterial hypertension rats
Pulmonary arterial hypertension (PAH) is a severe pulmonary vascular disease characterized by sustained increase in pulmonary arterial pressure and excessive thickening and remodeling of distal small pulmonary arteries. During disease progression, PAH include increase in mean pulmonary arterial pres...
Autor principal: | Lee, Jae Chul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association of Anatomists
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386927/ https://www.ncbi.nlm.nih.gov/pubmed/28417056 http://dx.doi.org/10.5115/acb.2017.50.1.60 |
Ejemplares similares
-
Retraction notice to “Therapeutic effect of prostaglandin E1 in monocrotaline-induced pulmonary arterial hypertension rats” by Lee JC (Anat Cell Biol 2017;50:60-8)
por: Lee, Jae Chul
Publicado: (2017) -
Maprotiline Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
por: Tong, Yi, et al.
Publicado: (2018) -
Arctigenin prevents monocrotaline-induced pulmonary arterial hypertension in rats
por: Jiang, Wei-Long, et al.
Publicado: (2019) -
Notopterol Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rat
por: Huang, Lin, et al.
Publicado: (2022) -
Inhibitory effects of formononetin on the monocrotaline-induced pulmonary arterial hypertension in rats
por: Wu, Yonghui, et al.
Publicado: (2020)